Summary: Ximelagatran is the first orally active direct thrombin inhibitor to be tested in Phase III clinical trials. After oral administration, ximelagatran is rapidly converted to its active ...
Acid secretion occurred in dogs with pouches of the entire stomach when the hydrochloride was administered subcutaneously, intramuscularly or orally. The maximal acid secretory rate and the pepsin ...